Esaote claims Ultrasound breakthrough:
This article was originally published in Clinica
Executive Summary
Esaote launched an ultra-high performance ultrasound device at the Radiological Society of North America meeting in Chicago last month. The Technos claims to incorporate a research breakthrough in probe technology from the Genova, Italy-based company. The Technos can visualise subtle vascular morphology and very slow blood flows, enabling high visibility of vascular detail, including the intimal lining of the carotid artery and minute leg vessels.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.